Emergency Three-Day Administration of Opioid Agonist Under 21 CFR 1306.07

Association of State and Territorial Health Officials. 11/02/2017 This two-page document provides guidance for practitioners who have neither registered with the Drug Enforcement Administration (DEA) nor obtained a waiver, and want to perform "emergency administration of narcotics...to relieve acute withdrawal symptoms while treatment arrangements are being made (i.e., the three-day rule)." Registration with DEA or a DATA 2000 waiver is not required when narcotic drugs are used incidentally to medical or surgical treatment for conditions other than addiction (e.g., an opioid-dependent patient who is admitted to a hospital for an issue other than opioid dependency is administered an opioid agonist, such as methadone or buprenorphine, to prevent opioid withdrawal while the primary condition is treated). (PDF)

Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 3, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news